Yantai Zhenghai Bio-Tech Co., Ltd.
Summary
Revenue :
000,000 M USD
Finance :
000,000 M USD
Earning Cap :
000,000 M USD
Invest :
000,000 M USD
R & D :
0000 People
Growth :
00% AGR
DIGDAL CAP
Overview
| General Introduction | Yantai Zhenghai Biotechnology Co., Ltd. was established in 2003 and successfully listed on May 16, 2017 (stock code: 300653). It is a national key research and development plan undertaking unit, a national "863" plan undertaking unit, and a high-tech enterprise. The company is based in the field of regenerative medicine and is located in the strategic emerging industry of the 13th Five Year Plan. It has been certified by the ISO 13485/ISO 9001 quality management system. The company has established high specification regenerative medical material research and development platforms such as the Shandong Medical Regenerative Repair Material Engineering Technology Research Center, Shandong Enterprise Technology Center, and Shandong Biological Regenerative Material Engineering Laboratory. The company emphasizes technological innovation and has a clear competitive advantage. We have applied for over 70 international and domestic patents, and our core patents have won the first prize of the Shandong Provincial Patent Award and the China Patent Excellence Award. The company's listed products are bio regenerative materials, among which soft tissue repair series products such as oral repair membranes, biofilms, and skin repair membranes have been widely used in multiple fields such as dentistry, head and neck surgery, neurosurgery, and have won the trust and support of tens of thousands of medical and patient users; The hard tissue repair product bone repair material is a functional scaffold material with significant clinical needs and guidance for bone damage repair, leading the industry in terms of project technology level. The company has undertaken more than 60 national and provincial level scientific and technological development projects, and has been approved as a national key research and development plan, a national "863" plan, a national torch plan, a national intellectual property demonstration enterprise, a national specialized, refined, and new "little giant" enterprise, a major independent innovation project in Shandong Province, the first Shandong Industrial Outstanding Contribution Award, one of the top 50 new material leading enterprises in Shandong Province, a demonstration enterprise for fulfilling social responsibility in Shandong Province, and a famous brand product in Shandong Province Famous brands in Shandong, various levels of technological invention awards, scientific and technological progress awards, and many other honors, it is a member unit of the China Medical Device Industry Association and a demonstration enterprise for the implementation of quality standards for medical device production in Shandong Province. The company is oriented towards meeting customer needs, and its marketing network covers all provinces, autonomous regions, and municipalities directly under the central government across the country. The company will adhere to the corporate vision of "becoming a leader in the field of regenerative medicine", and make positive contributions to improving the quality of life of the people, enhancing the level of social medical health, and promoting the innovative development of the biopharmaceutical industry. |
| Headquarter | Yantai |
| Establish Date | 10/22/2003 |
| Listed Code | 300653.SZ |
| Listed Date | 5/16/2017 |
| Chairman | Song Kan. |
| CEO | Song Kan. |
| Website | www.zhbio.com |
Buy Premium Now
$15/month billed now
View the full stack of insights immediately
Or 7 Days Free Charge for Trial
See feature available in the Trial and Premium
See our Solution and Servicetrial.solutionservice.trial
See our Uniquness and Value deliveringtrial.solutionservice.trial
